Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy

JAMA Network Open ◽

10.1001/jamanetworkopen.2021.14904 ◽

2021 ◽

Vol 4 (6) ◽

pp. e2114904

Author(s):

Huma Dar ◽

Annelie Johansson ◽

Anna Nordenskjöld ◽

Adina Iftimi ◽

Christina Yau ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Tamoxifen Therapy ◽

Estrogen Receptor Positive

Download Full-text

Cyclin D1 Expression and Patient Outcome After Tamoxifen Therapy in Estrogen Receptor Positive Breast Cancer

Journal of Korean Breast Cancer Society ◽

10.4048/jkbcs.2000.3.1.51 ◽

2000 ◽

Vol 3 (1) ◽

pp. 51

Author(s):

Sehwan Han ◽

Hong Yong Kim ◽

Kyeongmee Park ◽

Byung Noh Bae ◽

Ki Hwan Kim ◽

...

Keyword(s):

Breast Cancer ◽

Patient Outcome ◽

Estrogen Receptor ◽

Cyclin D1 ◽

Tamoxifen Therapy ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Re: Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/89.21.1631-a ◽

1997 ◽

Vol 89 (21) ◽

pp. 1631-1632

Author(s):

L. C. Panasci ◽

D. Melnychuk

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Lymph Nodes ◽

Cancer Patients ◽

Tamoxifen Therapy ◽

Breast Cancer Patients ◽

Estrogen Receptor Positive ◽

Negative Lymph Nodes

Download Full-text

Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/88.21.1529 ◽

1996 ◽

Vol 88 (21) ◽

pp. 1529-1542 ◽

Author(s):

B. Fisher ◽

J. Dignam ◽

J. Bryant ◽

A. DeCillis ◽

D. L. Wickerham ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Lymph Nodes ◽

Cancer Patients ◽

Tamoxifen Therapy ◽

Breast Cancer Patients ◽

Estrogen Receptor Positive ◽

Negative Lymph Nodes

Download Full-text

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

Cancer/Radiothérapie ◽

10.1016/s1278-3218(97)80011-x ◽

1997 ◽

Vol 1 (3) ◽

pp. 267

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Lymph Nodes ◽

Cancer Patients ◽

Tamoxifen Therapy ◽

Breast Cancer Patients ◽

Estrogen Receptor Positive ◽

Negative Lymph Nodes

Download Full-text

Cyclin D1 expression and patient outcome after tamoxifen therapy in estrogen receptor positive metastatic breast cancer

Oncology Reports ◽

10.3892/or.10.1.141 ◽

2003 ◽

Author(s):

Sehwan Han ◽

Kyeongmee Park ◽

Byung-Noe Bae ◽

Ki Kim ◽

Hong-Joo Kim ◽

...

Keyword(s):

Breast Cancer ◽

Patient Outcome ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Cyclin D1 ◽

Metastatic Breast ◽

Tamoxifen Therapy ◽

Estrogen Receptor Positive

Download Full-text

Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted

Case Medical Research ◽

10.31525/ct1-nct04185311 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Triple Negative ◽

Talimogene Laherparepvec ◽

Estrogen Receptor Positive

Download Full-text

Faculty Opinions recommendation of Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734565867.793581155 ◽

2020 ◽

Author(s):

David Potter

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Neoadjuvant Therapy ◽

Early Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Estrogen Receptor Positive

Download Full-text

Faculty Opinions recommendation of ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737201214.793572775 ◽

2020 ◽

Author(s):

Vijay Tiwari ◽

Deborah Lavin

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Therapeutic Response ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Reverse effect of chidamide on endocrine resistance in estrogen receptor-positive breast cancer

JOURNAL OF SHENZHEN UNIVERSITY SCIENCE AND ENGINEERING ◽

10.3724/sp.j.1249.2018.04339 ◽

2018 ◽

Vol 35 (4) ◽

pp. 339 ◽

Author(s):

You ZHOU ◽

Yan'an WANG ◽

Kun ZHANG ◽

Jingzhong ZHU ◽

Zhiqiang NING

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Resistance ◽

Reverse Effect ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Endocrine Disruptor Agent Nonyl Phenol Exerts An Estrogen-like Transcriptional Activity on Estrogen Receptor Positive Breast Cancer Cells

Current Medicinal Chemistry ◽

10.2174/09298673113209990169 ◽

2014 ◽

Vol 21 (5) ◽

pp. 630-640 ◽

Author(s):

A.A. Amaro ◽

A.I. Esposito ◽

V. Mirisola ◽

A. Mehilli ◽

C. Rosano ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Cells ◽

Endocrine Disruptor ◽

Breast Cancer Cells ◽

Transcriptional Activity ◽

Nonyl Phenol ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text